Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of heart failure"
DOI: 10.1002/ejhf.3699
Abstract: AIMS In clinical practice, simplifying the number of medication titration steps while maintaining safety may improve the likelihood of patients with heart failure (HF) achieving target doses of guideline-directed medical therapy (GDMT). The VELOCITY study… read more here.
Keywords: velocity study; tolerability; velocity; safety ... See more keywords